Iyuda Therapeutics
Leading the Fight Against Cancer, Infections, and Immune Disorders with Innovative Treatments
Leading the Fight Against Cancer, Infections, and Immune Disorders with Innovative Treatments
Iyuda Therapeutics is a pharmaceutical therapeutics company that is leading the fight against cancer, infections, and immune disorders with innovative treatments. Founded in 2014, the company operates in the biopharma, biotechnology, health and wellness, and pharmaceutical industries. Their latest milestone is a $1.39M Venture Round investment on 14 September 2023, although the specific investors are currently undisclosed. Iyuda Therapeutics is positioning itself as a key player in addressing pressing medical challenges and has the potential to make a significant impact in the healthcare and pharmaceutical sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $1.39M | - | 14 Sep 2023 |
No recent news or press coverage available for Iyuda Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
